Jiangsu Kanion Pharmaceutical Co.Ltd(600557) 3 announced on March 3 that Mr. Qiu Hongtao, the former representative of securities affairs, was no longer the representative of securities affairs of the company due to work adjustment, and appointed Ms. Chen Yanxi as the representative of securities affairs of the company to assist the Secretary of the board of directors Jiangsu Kanion Pharmaceutical Co.Ltd(600557) the 14th meeting of the 7th board of directors deliberated and approved the proposal on appointing Mr. Gao Haixin as the company’s deputy general manager, the proposal on appointing Mr. Wang chuanlei as the company’s deputy general manager, the proposal on appointing Mr. Pan Yu as the company’s deputy general manager and the proposal on appointing Mr. Xiao Anliang as the company’s chief financial officer Proposal on appointing Mr. Qiu Hongtao as the Secretary of the board of directors of the company. Nominated by Mr. Yang Yongchun, the general manager of the company, and reviewed by the nomination committee of the board of directors, the board of directors agreed to appoint Mr. Gao Haixin, Mr. Wang chuanlei and Mr. Pan Yu as the deputy general manager of the company, and agreed to appoint Mr. Xiao Anliang as the chief financial officer of the company to be responsible for the financial work of the company. Nominated by Mr. Xiao Wei, chairman of the company, and reviewed by the nomination committee of the board of directors, the board of directors agreed to appoint Mr. Qiu Hongtao as the Secretary of the board of directors of the company. Therefore, we agree that the board of directors shall appoint Mr. Gao Haixin, Mr. Wang chuanlei and Mr. Pan Yu as the deputy general manager of the company, Mr. Xiao Anliang as the chief financial officer of the company to be responsible for the financial work of the company, and Mr. Qiu Hongtao as the Secretary of the board of directors of the company.
© China Stock Market News